These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 23560831)

  • 21. General principles of cancer chemotherapy.
    Einhorn LH
    Conn Med; 1976 Mar; 40(3):159-68. PubMed ID: 765057
    [No Abstract]   [Full Text] [Related]  

  • 22. Medical equipment. PET projects.
    Health Serv J; 2004 Sep; 114(5924):38. PubMed ID: 15493794
    [No Abstract]   [Full Text] [Related]  

  • 23. PET screening of anticancer drugs. A faster route to drug/target evaluations in vivo.
    Fredriksson A; Stone-Elander S
    Methods Mol Med; 2003; 85():279-94. PubMed ID: 12710215
    [No Abstract]   [Full Text] [Related]  

  • 24. [18F]Fluorodeoxyglucose positron emission tomography for outcome prediction of mammalian target of rapamycin inhibitor therapy.
    De Giorgi U; Amadori D
    J Clin Oncol; 2010 May; 28(15):e236-7; author reply e238. PubMed ID: 20177016
    [No Abstract]   [Full Text] [Related]  

  • 25. Aiming for a direct hit: combining molecular imaging with targeted cancer therapy.
    Reilly RM
    J Nucl Med; 2009 Jul; 50(7):1017-9. PubMed ID: 19525475
    [No Abstract]   [Full Text] [Related]  

  • 26. Molecular imaging of epidermal growth factor receptor expression-activity at the kinase level in tumors with positron emission tomography.
    Gelovani JG
    Cancer Metastasis Rev; 2008 Dec; 27(4):645-53. PubMed ID: 18626573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of a novel Arg-Gly-Asp radioligand, 18F-AH111585, to determine changes in tumor vascularity after antitumor therapy.
    Morrison MS; Ricketts SA; Barnett J; Cuthbertson A; Tessier J; Wedge SR
    J Nucl Med; 2009 Jan; 50(1):116-22. PubMed ID: 19091899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safer cancer chemotherapy using a kinetically based experimental approach.
    Price LA; Hill BT
    Mt Sinai J Med; 1985 Jun; 52(6):452-9. PubMed ID: 3875025
    [No Abstract]   [Full Text] [Related]  

  • 29. P21-driven multifusion gene system for evaluating the efficacy of histone deacetylase inhibitors by in vivo molecular imaging and for transcription targeting therapy of cancer mediated by histone deacetylase inhibitor.
    Hsieh YJ; Hwu L; Chen YC; Ke CC; Chen FD; Wang HE; Lin KP; Yeh HH; Chang CW; Liu RS
    J Nucl Med; 2014 Apr; 55(4):678-85. PubMed ID: 24639460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positron emission tomography for modeling pathophysiological processes in vivo.
    Hendrikse NH; Luurtsema G; van der Veldt AA; Lubberink M
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):717-25. PubMed ID: 18729023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug latentiation in cancer chemotherapy.
    Workman P; Double JA
    Biomedicine; 1978 Oct; 28(5):255-62. PubMed ID: 369628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiological assessment of tumour response to anti-cancer drugs: time to reappraise.
    Nygren P; Blomqvist L; Bergh J; Aström G
    Acta Oncol; 2008; 47(2):316-8. PubMed ID: 18210304
    [No Abstract]   [Full Text] [Related]  

  • 33. Limited funding. Plan for PET scans draws docs' ire.
    Lee J
    Mod Healthc; 2013 Apr; 43(13):12. PubMed ID: 24006701
    [No Abstract]   [Full Text] [Related]  

  • 34. Positron emission tomography: a new investigational area for cancer research.
    Wells P; Harte RJ; Price P
    Clin Oncol (R Coll Radiol); 1996; 8(1):7-14. PubMed ID: 8688368
    [No Abstract]   [Full Text] [Related]  

  • 35. The RECIST (Response Evaluation Criteria in Solid Tumors) criteria: implications for diagnostic radiologists.
    Padhani AR; Ollivier L
    Br J Radiol; 2001 Nov; 74(887):983-6. PubMed ID: 11709461
    [No Abstract]   [Full Text] [Related]  

  • 36. [Resistance, the cause of failure in antineoplastic chemotherapies].
    Israel L
    Pathol Biol (Paris); 1989 Feb; 37(2):125-7. PubMed ID: 2652060
    [No Abstract]   [Full Text] [Related]  

  • 37. Thallium-201 imaging in the assessment of tumor response to anti-tumor treatments.
    Berk F; Demir H; Aktolun C
    Q J Nucl Med; 2003 Mar; 47(1):63-74. PubMed ID: 12714957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic failure of antineoplastic agents. Extracellular and cellular causes].
    Hofsli E
    Tidsskr Nor Laegeforen; 1991 Jan; 111(1):37-40. PubMed ID: 2000585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design of cancer chemotherapy: introductory remarks.
    Mihich E
    Antibiot Chemother (1971); 1980; 28():VII-X. PubMed ID: 7416723
    [No Abstract]   [Full Text] [Related]  

  • 40. [Specific histotropism of antineoplastic agents].
    Berti T
    Clin Ter; 1970 Nov; 55(4):293-303. PubMed ID: 4930868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.